Chronic insomnia

David N. Neubauer; Kelleen N. Flaherty

doi:10.1055/s-0029-1237125

Chronic insomnia

David N. Neubauer, Kelleen N. Flaherty

School of Medicine

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Chronic insomnia afflicts millions of people in the United States. It is associated with decreased quality of life, accidents, several comorbid conditions, increased morbidity, and substantial direct and indirect costs. Chronic insomnia is a multifactorial and individualized disorder. Its etiology may be cognitive or physiologic in nature (or both), and is more often than not associated with a comorbid condition, complicating its recognition, evaluation, and treatment. Effective nonpharmacotherapeutic (cognitivebehavioral therapy for insomnia) and pharmacotherapeutic (hypnotic medications) treatment modalities are available. Treatment of chronic insomnia can make a significant improvement in quality of life, and may also be associated with an improvement in comorbid conditions.

Original language	English (US)
Pages (from-to)	340-353
Number of pages	14
Journal	Seminars in neurology
Volume	29
Issue number	4
DOIs	https://doi.org/10.1055/s-0029-1237125
State	Published - 2009

Keywords

Chronic insomnia
Cognitivebehavioral therapy
Comorbidity
Hypnotic
Sleep

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1055/s-0029-1237125

Cite this

@article{e9482421af4d4e36bbae64d5e23b03f9,

title = "Chronic insomnia",

abstract = "Chronic insomnia afflicts millions of people in the United States. It is associated with decreased quality of life, accidents, several comorbid conditions, increased morbidity, and substantial direct and indirect costs. Chronic insomnia is a multifactorial and individualized disorder. Its etiology may be cognitive or physiologic in nature (or both), and is more often than not associated with a comorbid condition, complicating its recognition, evaluation, and treatment. Effective nonpharmacotherapeutic (cognitivebehavioral therapy for insomnia) and pharmacotherapeutic (hypnotic medications) treatment modalities are available. Treatment of chronic insomnia can make a significant improvement in quality of life, and may also be associated with an improvement in comorbid conditions.",

keywords = "Chronic insomnia, Cognitivebehavioral therapy, Comorbidity, Hypnotic, Sleep",

author = "Neubauer, {David N.} and Flaherty, {Kelleen N.}",

note = "Funding Information: Preparation of this Seminar was supported partly by grants from the Canadian Institutes of Health Research ( MT-42504 ) and the National Institute of Mental Health ( MH-079188 ). Funding Information: CMM has served as a consultant for Eli-Lilly, Merck, and Sanofi-Aventis and has received research grants from Organon, Merck, and Sanofi-Aventis. RB has served as a consultant for Merck and Sanofi-Aventis. ",

year = "2009",

doi = "10.1055/s-0029-1237125",

language = "English (US)",

volume = "29",

pages = "340--353",

journal = "Seminars in neurology",

issn = "0271-8235",

publisher = "Thieme Medical Publishers, Inc.",

number = "4",

}

TY - JOUR

T1 - Chronic insomnia

AU - Neubauer, David N.

AU - Flaherty, Kelleen N.

N1 - Funding Information: Preparation of this Seminar was supported partly by grants from the Canadian Institutes of Health Research ( MT-42504 ) and the National Institute of Mental Health ( MH-079188 ). Funding Information: CMM has served as a consultant for Eli-Lilly, Merck, and Sanofi-Aventis and has received research grants from Organon, Merck, and Sanofi-Aventis. RB has served as a consultant for Merck and Sanofi-Aventis.

PY - 2009

Y1 - 2009

N2 - Chronic insomnia afflicts millions of people in the United States. It is associated with decreased quality of life, accidents, several comorbid conditions, increased morbidity, and substantial direct and indirect costs. Chronic insomnia is a multifactorial and individualized disorder. Its etiology may be cognitive or physiologic in nature (or both), and is more often than not associated with a comorbid condition, complicating its recognition, evaluation, and treatment. Effective nonpharmacotherapeutic (cognitivebehavioral therapy for insomnia) and pharmacotherapeutic (hypnotic medications) treatment modalities are available. Treatment of chronic insomnia can make a significant improvement in quality of life, and may also be associated with an improvement in comorbid conditions.

AB - Chronic insomnia afflicts millions of people in the United States. It is associated with decreased quality of life, accidents, several comorbid conditions, increased morbidity, and substantial direct and indirect costs. Chronic insomnia is a multifactorial and individualized disorder. Its etiology may be cognitive or physiologic in nature (or both), and is more often than not associated with a comorbid condition, complicating its recognition, evaluation, and treatment. Effective nonpharmacotherapeutic (cognitivebehavioral therapy for insomnia) and pharmacotherapeutic (hypnotic medications) treatment modalities are available. Treatment of chronic insomnia can make a significant improvement in quality of life, and may also be associated with an improvement in comorbid conditions.

KW - Chronic insomnia

KW - Cognitivebehavioral therapy

KW - Comorbidity

KW - Hypnotic

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=70449384606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449384606&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1237125

DO - 10.1055/s-0029-1237125

M3 - Review article

C2 - 19742410

AN - SCOPUS:70449384606

SN - 0271-8235

VL - 29

SP - 340

EP - 353

JO - Seminars in neurology

JF - Seminars in neurology

IS - 4

ER -

Chronic insomnia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this